GeekWire Radio: Amgen and the state of Seattle biotech, with guest Luke Timmerman

Amgen dealt a blow to Seattle’s biotech business final week with the announcement that it is going to be closing its massive research-and-development campus on Elliott Bay, which dates again to its acquisition of Immunex greater than a decade in the past.

So what does this closure imply for the biotech business? Our visitor this week is Luke Timmerman, the veteran biotechnology journalist, who shares his perspective on Amgen’s choice and the broader state of biotechnology within the Seattle area. We discuss the important thing remaining gamers, together with Seattle Genetics, Alder BioPharmaceuticals, Adaptive Biotechnologies, Juno Therapeutics, the closely funded startup creating immunotherapies for treating most cancers.

Timmerman additionally provides us a sneak preview of his in-progress biography of biotech pioneer Leroy Hood. Timmerman, beforehand the nationwide biotech editor at Xconomy, struck out on his personal earlier this 12 months to complete his work on the guide.

The biotech dialog begins within the second phase of the present, on the 9:10 mark within the audio participant beneath. Additionally hear immediately by way of this MP3 file.

The present begins with our “Week in Geek” information roundup. Matters embrace the disintegration of Dash’s bid to amass T-Cell, and the continuing battle between Hachette and Amazon, which noticed a brand new growth simply this morning — as Amazon appealed to authors and readers to strain Hachette on the difficulty of e-book costs.

App of the Week: Alaska Airways’ app for iPhone, which was just lately redesigned.

Identify that Tech Tune: Are you aware which kind of laptop featured these sounds? Ship your reply to [email protected] for an opportunity to win a RainGlobe. From the pool of right solutions we’ll choose one individual at random to win the prize.